Andreas Krebs is an entrepreneur, investor, author and was Chairman of Merz KGaA until fall 2019. Andreas Krebs is one of the few Germans to have made it to the Executive Board and Corporate Americ
a in a ‘Big Pharma’ group. Today, Krebs runs his own venture capital company Cologne Invest with a friend and partner, which invests in young start-ups and growth companies in many sectors and the ‘new economy’.
